Moon Du Geon, Jin Myeong Heon, Lee Jeong Gu, Kim Je Jong, Kim Myung Gon, Cha Dae Ryong
Department of Urology, Korea University College of Medicine, Seoul, Korea.
BJU Int. 2004 Sep;94(4):571-5. doi: 10.1111/j.1464-410X.2004.05003.x.
To investigate the circadian variation of plasma antidiuretic hormone (ADH) and urine output in patients with severe nocturia (> three times per night) and to assess the effect of oral desmopressin on nocturnal urine output in these patients.
Twelve patients with severe nocturia and five age-matched controls without were assessed over 24 h (circadian sampling) during a 72-h hospital admission. Blood levels of ADH and changes of urine output were measured in the patients before and after the oral administration of desmopressin (0.2 mg, at 22.00 hours in the second day), and in the controls not treated with desmopressin.
Compared with the normal control, the patients had no diurnal variation in urine output and greater nocturnal urine production, associated with a lack of nocturnal increase in ADH level. Compared with the baseline urine output, desmopressin significantly decreased night-time (23.00-08.00 hour) urine output in the patients (P < 0.05). Desmopressin significantly increased the osmolality of night-time urine (P < 0.05), and there was no systemic adverse reaction.
Severe nocturia in a large proportion of elderly men with lower urinary tract symptoms is caused by nocturnal polyuria and natriuresis, because they have no nocturnal increase in ADH. These results suggest that desmopressin may be effective in decreasing nocturnal urine production in patients with severe nocturia who do not respond to conventional treatment.
研究重度夜尿症患者(每晚夜尿超过三次)血浆抗利尿激素(ADH)和尿量的昼夜变化,并评估口服去氨加压素对这些患者夜间尿量的影响。
在72小时的住院期间,对12例重度夜尿症患者和5例年龄匹配的无夜尿症对照者进行24小时(昼夜采样)评估。在口服去氨加压素(0.2毫克,于第二天22:00服用)前后,测量患者的ADH血药浓度和尿量变化,并测量未接受去氨加压素治疗的对照者的上述指标。
与正常对照组相比,患者尿量无昼夜变化,夜间尿量增加,且ADH水平夜间无升高。与基线尿量相比,去氨加压素显著降低了患者夜间(23:00至08:00)的尿量(P < 0.05)。去氨加压素显著提高了夜间尿液的渗透压(P < 0.05),且无全身不良反应。
大部分有下尿路症状的老年男性重度夜尿症是由夜间多尿和利钠引起的,因为他们夜间ADH没有升高。这些结果表明,去氨加压素可能对常规治疗无效的重度夜尿症患者减少夜间尿量有效。